Crossmark

Complement components are upregulated and correlate with disease progression in the TDP-43Q331K mouse model of amyotrophic lateral sclerosis

Crossref DOI link: https://doi.org/10.1186/s12974-018-1217-2

Published Online: 2018-06-01

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lee, John D. https://orcid.org/0000-0002-9976-7396
Levin, Samantha C.

Willis, Emily F.

Li, Rui

Woodruff, Trent M.

Noakes, Peter G.
Funding

Funding for this research was provided by:

Motor Neurone Disease Research Institute of Australia (GIA1429, GIA1547, GIA1865, GIA1830, PDF1604)

National Health and Medical Research Council (APP1105420)
License Information

Text and Data Mining valid from 2018-06-01
More Information

Article History

Received: 5 March 2018

Accepted: 24 May 2018

First Online: 1 June 2018

Ethics approval

: All experimental procedures were approved by the University of Queensland Animal Ethics Committee and complied with the policies and regulations regarding animal experimentation. They were conducted in accordance with the Queensland Government Animal Research Act 2001, associated Animal Care and Protection Regulations (2002 and 2008) and the Australian Code of Practice for the Care and Use of Animals for Scientific Purposes, 8th Edition (National Health and Medical Research Council, 2013). ARRIVE guidelines have been followed in the preparation of the manuscript.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.